Stroke – Pipeline Review, H1 2020

Global Markets Direct’s, ‘Stroke – Pipeline Review, H1 2020’, provides an overview of the Stroke pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Stroke, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Stroke and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

– The report provides a snapshot of the global therapeutic landscape of Stroke

– The report reviews pipeline therapeutics for Stroke by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Stroke therapeutics and enlists all their major and minor projects

– The report assesses Stroke therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Stroke

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Stroke

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Stroke pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

AbbVie Inc

Acorda Therapeutics Inc

Acticor Biotech SAS

advanceCor GmbH

Advanced BioMatrix Inc

AegisCN LLC

Aegle Therapeutics Corp

Affibody AB

Allife Medical Science and Technology Co Ltd

Allosteros Therapeutics Inc

Anavex Life Sciences Corp

Ankasa Regenerative Therapeutics Inc

Annovis Bio Inc

Anthos Therapeutics Inc

AntiRadical Therapeutics LLC

Antoxis Ltd

Apellis Pharmaceuticals Inc

Aposcience AG

APT Therapeutics Inc

AptaTargets SL

AriBio

ArmaGen Inc

Aronora Inc

Artelo Biosciences Inc

ArunA Biomedical Inc

Asta Pharmaceuticals Co Ltd

AstraZeneca Plc

Athersys Inc

Aurum Biosciences Ltd

Australia Medical Industries Pty Ltd

Avilex Pharma ApS

Axolo Pharma Inc

Band Therapeutics LLC

Bayer AG

Baylx Inc

Beijing Yinfeng Dingcheng Bioengineering Co Ltd

Bilix Co Ltd

BioAxone BioSciences Inc

Biogen Inc

Boehringer Ingelheim International GmbH

Brain-Gen LLC

Bristol-Myers Squibb Co

CardioVascular BioTherapeutics Inc

Celltrion Inc

Cenyx Biotech Inc

Cerebrum Therapeutics Inc

CHA Biotech Co Ltd

China Resources Emde Biological Pharmaceutical Co Ltd

Cogentis Therapeutics Inc

CohBar Inc

Constant Therapeutics LLC

Creative Medical Technology Holdings Inc

Crioestaminal Saude e Tecnologia SA

CSPC Pharmaceutical Group Ltd

Curacle Co Ltd

CuroNZ Ltd

Daewoong Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

DeckTherapeutics Inc

Deha Pharmaceutical LLC

DiaMedica Therapeutics Inc

Diffusion Pharmaceuticals Inc

Edvince AB

EIP Pharma LLC

Emerald Organic Products Inc

Epigen Biosciences Inc

Epygen Biotech Pvt Ltd

Ever Supreme Bio Technology Co Ltd

Evgen Pharma Plc

eXithera Pharmaceuticals Inc

Exscien Corp

F. Hoffmann-La Roche Ltd

Fortuna Fix Inc

Freeox Biotech SL

FUJIFILM Toyama Chemical Co Ltd

GABA Therapeutics Inc

Genentech Inc

Genervon Biopharmaceuticals LLC

Glucox Biotech AB

GNT Pharma Co Ltd

Guangzhou Cellprotek Pharmaceutical Co Ltd

Guangzhou Magpie Pharmaceutical Co Ltd

Guangzhou Recomgen Biotech Co Ltd

Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd

Gwoxi Stem Cell Applied Technology Co Ltd

Hefei Industrial Pharmaceutical Institute Co Ltd

Hefei Medical & Pharmaceutical Co Ltd

Hemostemix Inc

Hibernaid Inc

Hillhurst Biopharmaceuticals Inc

Hope Biosciences LLC

HSRx Group

Immunwork Inc

Instituto Biomar SA

International Stem Cell Corp

JCR Pharmaceuticals Co Ltd

Jeil Pharmaceutical Co Ltd

Jiangsu Ouwei Pharmaceutical Co Ltd

JT Pharmaceuticals Inc

Kai Nuo Bio Sci Co Ltd

Kyoto Drug Discovery & Development Co Ltd

Les Laboratoires Servier SAS

Living Cell Technologies Ltd

Lixte Biotechnology Holdings Inc

LTT Bio-Pharma Co Ltd

Lumosa Therapeutics Co Ltd

M et P Pharma AG

Mapreg SAS

Marizyme Inc

Meridigen Biotech Co Ltd

MetiMedi Pharmaceuticals Co Ltd

Mitoconix Bio Ltd

Modulation Therapeutics Inc

NC Medical Research Inc

NeuExcell Therapeutics Inc

Neuraly Inc

Neuren Pharmaceuticals Ltd

NeurExo Sciences LLC

Neurodon LLC

NeuroFix Therapeutics LLC

NeuroNascent Inc

NeurOp Inc

NeuroTrauma Sciences LLC

Neurotrope Bioscience Inc

New World Laboratories Inc

Nipro Corp

NoNO Inc

Novago Therapeutics AG

Novartis AG

NuvOx Pharma LLC

Nyrada Inc

Omniox Inc

OTR3 SAS

Paracelsus Neuroscience I LLC

Park Active Molecules

Pharmagenesis Inc

PharmatrophiX Inc

Pharmazz Inc

Pharmicell Co Ltd

Phoenix Biotechnology Inc

PhytoHealth Corp

Prediction BioSciences SAS

Primary Peptides Inc

Protheragen Inc

Q Therapeutics Inc

Regenera Pharma Ltd

Regeneron Pharmaceuticals Inc

RegeneRx Biopharmaceuticals Inc

ReNetX Bio

ReNeuron Group Plc

Rich Pharmaceuticals Inc

Rubicon Biotechnology Inc

Saje Pharma LLC

SanBio Inc

Saneron CCEL Therapeutics Inc

Saniona AB

Sansho Co Ltd

Savara Inc

Seneca Biopharma Inc

Sentan Pharma Inc

Shanghai Angecon Biotechnology Corp

Shanghai SIMR Biotech Co Ltd

Shanghai Zhimeng Biopharma Inc

Shin Poong Pharm Co Ltd

Shionogi & Co Ltd

Simcere Pharmaceutical Group

Stemedica Cell Technologies Inc

Stemetix Inc

Stream Biomedical Inc

SunBio Inc

Suzhou Pharmavan Cancer Research Center Co Ltd

Suzhou Ribo Life Sciences Co Ltd

TaiGen Biotechnology Co Ltd

Tasly Pharmaceutical Group Co Ltd

Techfields Pharma Co Ltd

The Cell Factory BVBA

TheraSource LLC

Theratome Bio Inc

Thrombolytic Science International LLC

TikoMed AB

TMS Co Ltd

Translational Sciences Inc

Valin Technologies Ltd

Vanworld Pharmaceutical (Rugao) Company Ltd

Vect-Horus SAS

Verseon Corp

Virogenomics BioDevelopment Inc

Virtici LLC

Xcelthera INC

Xonovo Inc

Yantai YenePharma Co Ltd

Zensun (Shanghai) Sci & Tech Co Ltd

Zhejiang Ausun Pharmaceutical Co Ltd

Zocere Inc

ZyVersa Therapeutics Inc

ZZ Biotech LLC

Table of Contents

Table of Contents

Introduction

Stroke - Overview

Stroke - Therapeutics Development

Stroke - Therapeutics Assessment

Stroke - Companies Involved in Therapeutics Development

Stroke - Drug Profiles

Stroke - Dormant Projects

Stroke - Discontinued Products

Stroke - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Stroke, H1 2020

Number of Products under Development by Companies, H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..3), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..4), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..5), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..6), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..7), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..8), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..9), H1 2020

Number of Products under Development by Universities/Institutes, H1 2020

Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020

Products under Development by Companies, H1 2020

Products under Development by Companies, H1 2020 (Contd..1), H1 2020

Products under Development by Companies, H1 2020 (Contd..2), H1 2020

Products under Development by Companies, H1 2020 (Contd..3), H1 2020

Products under Development by Companies, H1 2020 (Contd..4), H1 2020

Products under Development by Companies, H1 2020 (Contd..5), H1 2020

Products under Development by Companies, H1 2020 (Contd..6), H1 2020

Products under Development by Companies, H1 2020 (Contd..7), H1 2020

Products under Development by Companies, H1 2020 (Contd..8), H1 2020

Products under Development by Companies, H1 2020 (Contd..9), H1 2020

Products under Development by Companies, H1 2020 (Contd..10), H1 2020

Products under Development by Companies, H1 2020 (Contd..11), H1 2020

Products under Development by Companies, H1 2020 (Contd..12), H1 2020

Products under Development by Universities/Institutes, H1 2020

Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020

Number of Products by Stage and Target, H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..2), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..3), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..4), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..5), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..2), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..3), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..4), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..5), H1 2020

Number of Products by Stage and Route of Administration, H1 2020

Number of Products by Stage and Molecule Type, H1 2020

Stroke – Pipeline by AbbVie Inc, H1 2020

Stroke – Pipeline by Acorda Therapeutics Inc, H1 2020

Stroke – Pipeline by Acticor Biotech SAS, H1 2020

Stroke – Pipeline by advanceCor GmbH, H1 2020

Stroke – Pipeline by Advanced BioMatrix Inc, H1 2020

Stroke – Pipeline by AegisCN LLC, H1 2020

Stroke – Pipeline by Aegle Therapeutics Corp, H1 2020

Stroke – Pipeline by Affibody AB, H1 2020

Stroke – Pipeline by Allife Medical Science and Technology Co Ltd, H1 2020

Stroke – Pipeline by Allosteros Therapeutics Inc, H1 2020

Stroke – Pipeline by Anavex Life Sciences Corp, H1 2020

Stroke – Pipeline by Ankasa Regenerative Therapeutics Inc, H1 2020

Stroke – Pipeline by Annovis Bio Inc, H1 2020

Stroke – Pipeline by Anthos Therapeutics Inc, H1 2020

Stroke – Pipeline by AntiRadical Therapeutics LLC, H1 2020

Stroke – Pipeline by Antoxis Ltd, H1 2020

Stroke – Pipeline by Apellis Pharmaceuticals Inc, H1 2020

Stroke – Pipeline by Aposcience AG, H1 2020

Stroke – Pipeline by APT Therapeutics Inc, H1 2020

Stroke – Pipeline by AptaTargets SL, H1 2020

Stroke – Pipeline by AriBio, H1 2020

Stroke – Pipeline by ArmaGen Inc, H1 2020

Stroke – Pipeline by Aronora Inc, H1 2020

Stroke – Pipeline by Artelo Biosciences Inc, H1 2020

Stroke – Pipeline by ArunA Biomedical Inc, H1 2020

Stroke – Pipeline by Asta Pharmaceuticals Co Ltd, H1 2020

Stroke – Pipeline by AstraZeneca Plc, H1 2020

Stroke – Pipeline by Athersys Inc, H1 2020

Stroke – Pipeline by Aurum Biosciences Ltd, H1 2020

Stroke – Pipeline by Australia Medical Industries Pty Ltd, H1 2020

Stroke – Pipeline by Avilex Pharma ApS, H1 2020

Stroke – Pipeline by Axolo Pharma Inc, H1 2020

Stroke – Pipeline by Band Therapeutics LLC, H1 2020

Stroke – Pipeline by Bayer AG, H1 2020

Stroke – Pipeline by Baylx Inc, H1 2020

Stroke – Pipeline by Beijing Yinfeng Dingcheng Bioengineering Co Ltd, H1 2020

Stroke – Pipeline by Bilix Co Ltd, H1 2020

Stroke – Pipeline by BioAxone BioSciences Inc, H1 2020

Stroke – Pipeline by Biogen Inc, H1 2020

Stroke – Pipeline by Boehringer Ingelheim International GmbH, H1 2020

Stroke – Pipeline by Brain-Gen LLC, H1 2020

Stroke – Pipeline by Bristol-Myers Squibb Co, H1 2020

Stroke – Pipeline by CardioVascular BioTherapeutics Inc, H1 2020

Stroke – Pipeline by Celltrion Inc, H1 2020

Stroke – Pipeline by Cenyx Biotech Inc, H1 2020

Stroke – Pipeline by Cerebrum Therapeutics Inc, H1 2020

Stroke – Pipeline by CHA Biotech Co Ltd, H1 2020

Stroke – Pipeline by China Resources Emde Biological Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Cogentis Therapeutics Inc, H1 2020

Stroke – Pipeline by CohBar Inc, H1 2020

Stroke – Pipeline by Constant Therapeutics LLC, H1 2020

Stroke – Pipeline by Creative Medical Technology Holdings Inc, H1 2020

Stroke – Pipeline by Crioestaminal Saude e Tecnologia SA, H1 2020

Stroke – Pipeline by CSPC Pharmaceutical Group Ltd, H1 2020

Stroke – Pipeline by Curacle Co Ltd, H1 2020

Stroke – Pipeline by CuroNZ Ltd, H1 2020

Stroke – Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Daiichi Sankyo Co Ltd, H1 2020

Stroke – Pipeline by DeckTherapeutics Inc, H1 2020

Stroke – Pipeline by Deha Pharmaceutical LLC, H1 2020

Stroke – Pipeline by DiaMedica Therapeutics Inc, H1 2020

Stroke – Pipeline by Diffusion Pharmaceuticals Inc, H1 2020

Stroke – Pipeline by Edvince AB, H1 2020

Stroke – Pipeline by EIP Pharma LLC, H1 2020

Stroke – Pipeline by Emerald Organic Products Inc, H1 2020

Stroke – Pipeline by Epigen Biosciences Inc, H1 2020

Stroke – Pipeline by Epygen Biotech Pvt Ltd, H1 2020

Stroke – Pipeline by Ever Supreme Bio Technology Co Ltd, H1 2020

Stroke – Pipeline by Evgen Pharma Plc, H1 2020

Stroke – Pipeline by eXithera Pharmaceuticals Inc, H1 2020

Stroke – Pipeline by Exscien Corp, H1 2020

Stroke – Pipeline by F. Hoffmann-La Roche Ltd, H1 2020

Stroke – Pipeline by Fortuna Fix Inc, H1 2020

Stroke – Pipeline by Freeox Biotech SL, H1 2020

Stroke – Pipeline by FUJIFILM Toyama Chemical Co Ltd, H1 2020

Stroke – Pipeline by GABA Therapeutics Inc, H1 2020

Stroke – Pipeline by Genentech Inc, H1 2020

Stroke – Pipeline by Genervon Biopharmaceuticals LLC, H1 2020

Stroke – Pipeline by Glucox Biotech AB, H1 2020

Stroke – Pipeline by GNT Pharma Co Ltd, H1 2020

Stroke – Pipeline by Guangzhou Cellprotek Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Guangzhou Recomgen Biotech Co Ltd, H1 2020

Stroke – Pipeline by Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Gwoxi Stem Cell Applied Technology Co Ltd, H1 2020

Stroke – Pipeline by Hefei Industrial Pharmaceutical Institute Co Ltd, H1 2020

Stroke – Pipeline by Hefei Medical & Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Hemostemix Inc, H1 2020

Stroke – Pipeline by Hibernaid Inc, H1 2020

Stroke – Pipeline by Hillhurst Biopharmaceuticals Inc, H1 2020

Stroke – Pipeline by Hope Biosciences LLC, H1 2020

Stroke – Pipeline by HSRx Group, H1 2020

Stroke – Pipeline by Immunwork Inc, H1 2020

Stroke – Pipeline by Instituto Biomar SA, H1 2020

Stroke – Pipeline by International Stem Cell Corp, H1 2020

Stroke – Pipeline by JCR Pharmaceuticals Co Ltd, H1 2020

Stroke – Pipeline by Jeil Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Jiangsu Ouwei Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by JT Pharmaceuticals Inc, H1 2020

Stroke – Pipeline by Kai Nuo Bio Sci Co Ltd, H1 2020

Stroke – Pipeline by Kyoto Drug Discovery & Development Co Ltd, H1 2020

Stroke – Pipeline by Les Laboratoires Servier SAS, H1 2020

Stroke – Pipeline by Living Cell Technologies Ltd, H1 2020

Stroke – Pipeline by Lixte Biotechnology Holdings Inc, H1 2020

Stroke – Pipeline by LTT Bio-Pharma Co Ltd, H1 2020

Stroke – Pipeline by Lumosa Therapeutics Co Ltd, H1 2020

Stroke – Pipeline by M et P Pharma AG, H1 2020

Stroke – Pipeline by Mapreg SAS, H1 2020

Stroke – Pipeline by Marizyme Inc, H1 2020

Stroke – Pipeline by Meridigen Biotech Co Ltd, H1 2020

Stroke – Pipeline by MetiMedi Pharmaceuticals Co Ltd, H1 2020

Stroke – Pipeline by Mitoconix Bio Ltd, H1 2020

Stroke – Pipeline by Modulation Therapeutics Inc, H1 2020

Stroke – Pipeline by NC Medical Research Inc, H1 2020

Stroke – Pipeline by NeuExcell Therapeutics Inc, H1 2020

Stroke – Pipeline by Neuraly Inc, H1 2020

Stroke – Pipeline by Neuren Pharmaceuticals Ltd, H1 2020

Stroke – Pipeline by NeurExo Sciences LLC, H1 2020

Stroke – Pipeline by Neurodon LLC, H1 2020

Stroke – Pipeline by NeuroFix Therapeutics LLC, H1 2020

Stroke – Pipeline by NeuroNascent Inc, H1 2020

Stroke – Pipeline by NeurOp Inc, H1 2020

Stroke – Pipeline by NeuroTrauma Sciences LLC, H1 2020

Stroke – Pipeline by Neurotrope Bioscience Inc, H1 2020

Stroke – Pipeline by New World Laboratories Inc, H1 2020

Stroke – Pipeline by Nipro Corp, H1 2020

Stroke – Pipeline by NoNO Inc, H1 2020

Stroke – Pipeline by Novago Therapeutics AG, H1 2020

Stroke – Pipeline by Novartis AG, H1 2020

Stroke – Pipeline by NuvOx Pharma LLC, H1 2020

Stroke – Pipeline by Nyrada Inc, H1 2020

Stroke – Pipeline by Omniox Inc, H1 2020

Stroke – Pipeline by OTR3 SAS, H1 2020

Stroke – Pipeline by Paracelsus Neuroscience I LLC, H1 2020

Stroke – Pipeline by Park Active Molecules, H1 2020

Stroke – Pipeline by Pharmagenesis Inc, H1 2020

Stroke – Pipeline by PharmatrophiX Inc, H1 2020

Stroke – Pipeline by Pharmazz Inc, H1 2020

Stroke – Pipeline by Pharmicell Co Ltd, H1 2020

Stroke – Pipeline by Phoenix Biotechnology Inc, H1 2020

Stroke – Pipeline by PhytoHealth Corp, H1 2020

Stroke – Pipeline by Prediction BioSciences SAS, H1 2020

Stroke – Pipeline by Primary Peptides Inc, H1 2020

Stroke – Pipeline by Protheragen Inc, H1 2020

Stroke – Pipeline by Q Therapeutics Inc, H1 2020

Stroke – Pipeline by Regenera Pharma Ltd, H1 2020

Stroke – Pipeline by Regeneron Pharmaceuticals Inc, H1 2020

Stroke – Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2020

Stroke – Pipeline by ReNetX Bio, H1 2020

Stroke – Pipeline by ReNeuron Group Plc, H1 2020

Stroke – Pipeline by Rich Pharmaceuticals Inc, H1 2020

Stroke – Pipeline by Rubicon Biotechnology Inc, H1 2020

Stroke – Pipeline by Saje Pharma LLC, H1 2020

Stroke – Pipeline by SanBio Inc, H1 2020

Stroke – Pipeline by Saneron CCEL Therapeutics Inc, H1 2020

Stroke – Pipeline by Saniona AB, H1 2020

Stroke – Pipeline by Sansho Co Ltd, H1 2020

Stroke – Pipeline by Savara Inc, H1 2020

Stroke – Pipeline by Seneca Biopharma Inc, H1 2020

Stroke – Pipeline by Sentan Pharma Inc, H1 2020

Stroke – Pipeline by Shanghai Angecon Biotechnology Corp, H1 2020

Stroke – Pipeline by Shanghai SIMR Biotech Co Ltd, H1 2020

Stroke – Pipeline by Shanghai Zhimeng Biopharma Inc, H1 2020

Stroke – Pipeline by Shin Poong Pharm Co Ltd, H1 2020

Stroke – Pipeline by Shionogi & Co Ltd, H1 2020

Stroke – Pipeline by Simcere Pharmaceutical Group, H1 2020

Stroke – Pipeline by Stemedica Cell Technologies Inc, H1 2020

Stroke – Pipeline by Stemetix Inc, H1 2020

Stroke – Pipeline by Stream Biomedical Inc, H1 2020

Stroke – Pipeline by SunBio Inc, H1 2020

Stroke – Pipeline by Suzhou Pharmavan Cancer Research Center Co Ltd, H1 2020

Stroke – Pipeline by Suzhou Ribo Life Sciences Co Ltd, H1 2020

Stroke – Pipeline by TaiGen Biotechnology Co Ltd, H1 2020

Stroke – Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2020

Stroke – Pipeline by Techfields Pharma Co Ltd, H1 2020

Stroke – Pipeline by The Cell Factory BVBA, H1 2020

Stroke – Pipeline by TheraSource LLC, H1 2020

Stroke – Pipeline by Theratome Bio Inc, H1 2020

Stroke – Pipeline by Thrombolytic Science International LLC, H1 2020

Stroke – Pipeline by TikoMed AB, H1 2020

Stroke – Pipeline by TMS Co Ltd, H1 2020

Stroke – Pipeline by Translational Sciences Inc, H1 2020

Stroke – Pipeline by Valin Technologies Ltd, H1 2020

Stroke – Pipeline by Vanworld Pharmaceutical (Rugao) Company Ltd, H1 2020

Stroke – Pipeline by Vect-Horus SAS, H1 2020

Stroke – Pipeline by Verseon Corp, H1 2020

Stroke – Pipeline by Virogenomics BioDevelopment Inc, H1 2020

Stroke – Pipeline by Virtici LLC, H1 2020

Stroke – Pipeline by Xcelthera INC, H1 2020

Stroke – Pipeline by Xonovo Inc, H1 2020

Stroke – Pipeline by Yantai YenePharma Co Ltd, H1 2020

Stroke – Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H1 2020

Stroke – Pipeline by Zhejiang Ausun Pharmaceutical Co Ltd, H1 2020

Stroke – Pipeline by Zocere Inc, H1 2020

Stroke – Pipeline by ZyVersa Therapeutics Inc, H1 2020

Stroke – Pipeline by ZZ Biotech LLC, H1 2020

Stroke – Dormant Projects, H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..1), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..2), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..3), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..4), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..5), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..6), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..7), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..8), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..9), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..10), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..11), H1 2020

Stroke – Dormant Projects, H1 2020 (Contd..12), H1 2020

Stroke – Discontinued Products, H1 2020

Stroke – Discontinued Products, H1 2020 (Contd..1), H1 2020

Stroke – Discontinued Products, H1 2020 (Contd..2), H1 2020

List of Figures

List of Figures

Number of Products under Development for Stroke, H1 2020

Number of Products under Development by Companies, H1 2020

Number of Products under Development by Universities/Institutes, H1 2020

Number of Products by Top 10 Targets, H1 2020

Number of Products by Stage and Top 10 Targets, H1 2020

Number of Products by Top 10 Mechanism of Actions, H1 2020

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020

Number of Products by Top 10 Routes of Administration, H1 2020

Number of Products by Stage and Top 10 Routes of Administration, H1 2020

Number of Products by Top 10 Molecule Types, H1 2020

Number of Products by Stage and Top 10 Molecule Types, H1 2020

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports